Drs. Dawn Hershman and Primo Lara elected group co-chairs-elect of SWOG Cancer Research Network
2023-05-16
(Press-News.org)
The board of governors of the SWOG Cancer Research Network has elected Primo N. Lara, Jr., MD, and Dawn L. Hershman, MD, MS, as group co-chairs-elect. The two will serve in that capacity until the term of the current group chair, Charles D. Blanke, MD, ends in spring 2025. They will then begin a six-year term as SWOG’s first group co-chairs.
In a joint statement, Hershman and Lara said, “We both understand that the success of SWOG has been fundamentally anchored in collaborative interdisciplinary team science. We are convinced that a multi-PI approach at the group chair level truly represents SWOG’s highly successful team-based nature.”
“We believe that the breadth and depth of our experiences and skillsets in clinical and translational cancer research within SWOG and across the NCTN and NCORP are so highly complementary and synergistic that we expect nothing more than even greater impact of SWOG’s activities into the foreseeable future.”
Hershman is an American Cancer Society Professor of Medicine and Epidemiology and interim chief of the Division of Hematology/Oncology at Columbia University Irving Medical Center. She is also deputy director of the Herbert Irving Comprehensive Cancer Center. Within SWOG, she serves as SWOG’s vice chair for NCI Community Oncology Research Program (NCORP) research.
Lara is professor of medicine and executive associate dean for cancer programs at the University of California Davis School of Medicine. He is also director of the NCI-designated UC Davis Comprehensive Cancer Center, and within SWOG he serves as the group’s deputy chair and vice chair of operations.
SWOG Cancer Research Network is part of the National Cancer Institute's National Clinical Trials Network and the NCI Community Oncology Research Program and is part of the oldest and largest publicly funded cancer research network in the nation. SWOG has more than 18,000 members in 45 states and nine foreign countries who design and conduct clinical trials to improve the lives of people with cancer. SWOG trials have led to the approval of 14 cancer
END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2023-05-16
Boulder, Colo., USA: The Geological Society of America (GSA) is pleased to announce the upcoming 2023 GSA Rocky Mountain Section Meeting to be held from 23–25 May in Fort Collins, Colorado, USA. This highly anticipated event will provide a dynamic platform for scientists, researchers, industry professionals, and students to exchange ideas, present research findings, and foster collaborations. The meeting will feature a wide range of engaging sessions, a plenary lecture on climate intervention, scientific field trips, informative short courses, and impactful mentoring programs ...
2023-05-16
COMBINEDBrain’s Founder and Director, Dr. Terry Jo Bichell, understands the power of collaboration. In her years as a neuroscientist, advocate, and rare patient parent, she has witnessed the field of neurodevelopment transform from a broad focus on autism or intellectual disability, to an era based on rare genetic disorders. When new disorders are identified, Patient Advocacy Organizations spring up, led by passionate parents with the drive and determination to cure their children. Some of these organizations represent as many as 10,000 patients, some as few as 10. No matter their size, each organization must follow a similar path to ...
2023-05-16
Liquid biopsy is increasingly stepping up as a non-invasive approach in detecting and tracking circulating tumor DNA (ctDNA) in blood and providing crucial insights into the dynamics of cancer evolution and intra-tumor heterogeneity as drivers of cancer drug resistance.
One main limitation of liquid biopsy to-date is the low sensitivity of current approaches in tumor types that do not shed enough DNA into the bloodstream, including pancreatic cancer.
Co-led by VHIO’s Rodrigo A. Toledo, a study published in Genome Medicine (1) reports on the development of a novel ctDNA-based approach, Aneuploidy in Circulating Tumor DNA ...
2023-05-16
Researchers at Rutgers University have found a major flaw in the way that algorithms designed to detect "fake news" evaluate the credibility of online news stories.
Most of these algorithms rely on a credibility score for the "source" of the article, rather than assessing the credibility of each individual article, the researchers said.
"It is not the case that all news articles published by sources labeled 'credible' (e.g., The New York Times) are accurate, nor is it the case that every article published by sources labeled 'noncredible' publications are 'fake news,'" ...
2023-05-16
Spooked by volatile reports from the Silicon Valley Bank in early March, many customers panicked and withdrew their money, creating the largest bank failure since the 2007-2008 financial crisis. The problem — investors and customers lost confidence in the bank, proving the perception of a banks’ reliability can significantly impact its success.
Investors tend to respond negatively to volatility in firms’ performance. To mitigate investors’ concerns, when some banks receive extremely high income, they occasionally delay reporting that amount until a later date when the income ...
2023-05-16
“[...] we have developed a fully automated calling algorithm for determining B and T cell clonality from NGS [next-generation sequencing] data, with greater sensitivity than previously developed models.”
BUFFALO, NY- May 16, 2023 – A new research paper was published in Oncotarget's Volume 14 on May 12, 2023, entitled, “Development and implementation of an automated and highly accurate reporting process for NGS-based clonality testing.”
B and T cells undergo random recombination of the VH/DH/JH portions of the immunoglobulin loci (B cell) and T-cell receptors before becoming ...
2023-05-16
“This study now links Msi 1 to PD-L1.”
BUFFALO, NY- May 16, 2023 – A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 9, entitled, “Increased expression of musashi 1 on breast cancer cells has implication to understand dormancy and survival in bone marrow.”
Breast cancer (BC) stem cells (CSCs) resist treatment and can exist as dormant cells in tissues such as the bone marrow (BM). Years before clinical diagnosis, BC cells (BCCs) could migrate from the primary site where the BM niche ...
2023-05-16
Irvine, Calif., May 16, 2023 — The MGAT5 glycosylation enzyme plays a crucial role in brain development, according to a study by University of California, Irvine researchers, a discovery that may contribute to new therapeutic purposes for neural stem cells.
Neurons, astrocytes and oligodendrocytes are the final mature cells of the brain and spinal cord formed by neural stem cells. Each has distinct and key functions. Neurons transmit signals, astrocytes help modify those signals, and oligodendrocytes ...
2023-05-16
Like the lymphatic system in the body, the glymphatic system in the brain clears metabolic waste and distributes nutrients and other important compounds. Impairments in this system may contribute to brain diseases, such as neurodegenerative diseases and stroke.
A team of researchers in the McKelvey School of Engineering at Washington University in St. Louis has found a noninvasive and nonpharmaceutical method to influence glymphatic transport using focused ultrasound, opening the opportunity to use the method to further study brain diseases and brain function. Results of the work are published in the Proceedings ...
2023-05-16
The prize, now in its 10th year, is given annually to at least six early-career scientists based in the New York City area by The Pershing Square Sohn Cancer Research Alliance. Prizes are awarded to scientists who are pursuing innovative cancer research and taking risks that might preclude them from traditional funding. Winners receive $250,000 a year for up to three years and access to networking opportunities and an annual retreat with past winners.
For Dr. Simon, the prize will allow him to apply his knowledge as a neuroscientist to cancer research. “I'm not a traditional cancer biologist,” said Dr. ...
LAST 30 PRESS RELEASES:
[Press-News.org] Drs. Dawn Hershman and Primo Lara elected group co-chairs-elect of SWOG Cancer Research Network
